TWD 695.0
(-3.34%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 3.03 Billion TWD | 117.7% |
2022 | 1.39 Billion TWD | 85.65% |
2021 | 749.73 Million TWD | 29.62% |
2020 | 578.42 Million TWD | 89.63% |
2019 | 305.03 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 1.17 Billion TWD | 63.63% |
2024 Q1 | 716.13 Million TWD | 26.61% |
2023 Q2 | 692.02 Million TWD | -33.42% |
2023 Q4 | 565.6 Million TWD | -22.85% |
2023 FY | 3.03 Billion TWD | 117.7% |
2023 Q1 | 1.03 Billion TWD | 157.35% |
2023 Q3 | 733.16 Million TWD | 5.94% |
2022 Q3 | 568.88 Million TWD | 0.0% |
2022 FY | 1.39 Billion TWD | 85.65% |
2022 Q4 | 403.86 Million TWD | -29.01% |
2021 FY | 749.73 Million TWD | 29.62% |
2020 FY | 578.42 Million TWD | 89.63% |
2019 FY | 305.03 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Grape King Bio Ltd | 1.45 Billion TWD | -108.583% |
Standard Chem & Pharm CO., LTD. | 834.88 Million TWD | -262.941% |
Maywufa Company Ltd. | 169.09 Million TWD | -1691.944% |
ScinoPharm Taiwan, Ltd. | 287.05 Million TWD | -955.593% |
Lotus Pharmaceutical Co., Ltd. | 4.1 Billion TWD | 26.195% |
LIWANLI Innovation Co., Ltd. | 5.1 Million TWD | -59279.62% |
YungShin Global Holding Corporation | 827.3 Million TWD | -266.267% |
PhytoHealth Corporation | -47.11 Million TWD | 6531.101% |
SCI Pharmtech, Inc. | 294.72 Million TWD | -928.139% |
Formosa Laboratories, Inc. | 126.24 Million TWD | -2300.246% |
PharmaEssentia Corporation | -623.83 Million TWD | 585.728% |